Cargando…
Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
PURPOSE: The aim of our study was to assess dermatological changes in transgender people after the start of gender-affirming hormonal treatment (GAHT) and to investigate whether various hormonal preparations differently affect dermatological changes in trans AFAB (assigned female at birth) people. M...
Autores principales: | Cocchetti, C., Castellini, G., Maggi, M., Romani, A., Vignozzi, L., Greenman, Y., den Heijer, M., T’Sjoen, G., Fisher, A. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023754/ https://www.ncbi.nlm.nih.gov/pubmed/36348253 http://dx.doi.org/10.1007/s40618-022-01944-x |
Ejemplares similares
-
The ENIGI (European Network for the Investigation of Gender Incongruence) Study: Overview of Acquired Endocrine Knowledge and Future Perspectives
por: Cocchetti, Carlotta, et al.
Publicado: (2022) -
OR27-05 Sexual Desire Changes in Transgender Individuals upon Initiation of Hormone Treatment; Results from the Longitudinal ENIGI Study
por: Defreyne, Justine, et al.
Publicado: (2020) -
SAT-745 Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence (ENIGI)
por: Defreyne, Justine, et al.
Publicado: (2020) -
Positive and Negative Affect Changes during Gender-Affirming Hormonal Treatment: Results from the European Network for the Investigation of Gender Incongruence (ENIGI)
por: Matthys, Imke, et al.
Publicado: (2021) -
Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
por: Kuijpers, Suzanne M E, et al.
Publicado: (2021)